SEP 20, 2015 7:56 AM PDT

Childhood Leukemia and Living near Heavily Used Roads

WRITTEN BY: Ilene Schneider

The risk of acute leukemia in children living close to heavily used roads has been the focus of a recent study by Inserm researchers from CRESS (Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre, Inserm -- Paris Descartes University -- University of Paris 13 -- Paris Diderot University -- INRA). The results show that the incidence of new cases of myeloblastic leukemia (418 of 2,760 cases of leukemia) was 30 percent higher in children in the population whose home was within 150 meters of heavily used roads, and had a combined length of over 260 meters within this radius.
Leukemia is 30 percent higher in children living near heavily used roads. 
The research team considered all 2,760 cases of leukemia diagnosed in children under 15 years of age in metropolitan France over the 2002-2007 period. The results show that the incidence of new cases of myeloblastic leukemia (418 of 2,760 cases of leukemia) was 30 percent higher in children in the denser population area. In contrast, this association was not observed for the more common, lymphoblastic type of leukemia (2,275 cases). The researchers particularly studied the case of the Île-de-France region of Paris with the help of data modelled by Airparif, which is responsible for the monitoring of air quality in Ile-de-France. These results are published in the American Journal of Epidemiology and reported in Science Daily. 
 
Cancer touches more than 1,700 children under 15 annually in France, which has a population of 11 million children. Surveillance has been provided by the French National Registry of Childhood Haematopoietic Malignancies since 1990, and by the French National Registry of Childhood Solid Tumors since 2000. Leukemias (blood cancers), with 470 new cases each year, are the most common childhood cancers, and are mainly acute lymphoblastic leukemias. "Myeloblastic" or "myeloid" leukemia, another type of leukemia, affects myeloid stem cells, which give rise to the red blood cells. Today, 5-year survival following childhood leukemia is more than 80 percent.
 
The GEOCAP program (GEOlocation Study of Paediatric CAncers) studies the role of environmental exposure in the occurrence of cancer in children under 15. One hypothesis is that there is an increased risk of leukemia in children living close to heavily used roads. The increased risk of myeloblastic leukemia for adults with occupational exposure to benzene is known.
 
The EPICEA (Epidemiology of Childhood and Adolescent Cancers) team, directed by Jacqueline Clavel, Inserm Research Director, at CRESS, has reported the results of a study on the incidence of leukemias in children living close to heavily used roads. It enabled the assessment of exposure level to one or more risk factors. All 2,760 cases of childhood leukemia diagnosed in metropolitan France between 2002 and 2007 were included in the study, and compared to a contemporary sample of 30,000 control children representative of the metropolitan population, and constituted in collaboration with the French National Institute of Statistics and Economic Studies (INSEE).
 
According to Jacqueline Clavel, Inserm Research Director, "The frequency of myeloblastic type leukemias was 30% higher in children living within a 150 m radius of heavily used roads, and where the combined length of road sections within this radius exceeded 260 m." There was no association between acute lymphoblastic leukemias -- the most common -- and the atmospheric concentration of nitrogen dioxide, distance or combined length of heavily used roads in the vicinity of dwellings.
 
The researchers emphasized the Île-de-France region of Paris, the most urbanized region. They observed that the risk of childhood acute myeloblastic leukemia was double in Île-de-France children whose residences were the most exposed to traffic.
 

About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAR 23, 2020
Genetics & Genomics
MAR 23, 2020
Diagnosing Cancer by Looking for Microbial DNA in the Blood
Liquid biopsies aim to diagnose a disease with only a bit of biological fluid, usually blood.
MAY 18, 2020
Cancer
MAY 18, 2020
The threat of climate change extends to cancer progression
A study appearing in the American Cancer Society’s CA: A Cancer Journal for Clinicians argues that climate change ...
MAY 21, 2020
Drug Discovery & Development
MAY 21, 2020
Molecular 'Switch' Makes Autoimmune Drugs Fight Cancer
Researchers from the Antibody and Vaccine Group at the University of Southampton, England, have identified a way to repu ...
MAY 19, 2020
Cancer
MAY 19, 2020
Great ape genomes closer to human tumors than human genomes
A new study analyzing cancer from an evolutionary perspective reports that the distribution of mutations in human tumors ...
MAY 14, 2020
Drug Discovery & Development
MAY 14, 2020
Therapeutic for Gastrointestinal Tumors
The FDA has approved ripretinib (Qinlock) which is the first drug for fourth-line treatment of advanced gastrointestinal ...
MAY 30, 2020
Cancer
MAY 30, 2020
Linking an Aggressive Tumor Factor to the Innate Immune Response
Epithelial Ovarian Cancer (EOC) is a cancer of the fallopian tubes with a low five-year survival rate with a tendency to ...
Loading Comments...